John Haanen Selected Research

John Haanen Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 07/2004
15	Melanoma (Melanoma, Malignant) 03/2024 - 07/2004
15	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 07/2005
5	Kidney Neoplasms (Kidney Cancer) 01/2022 - 09/2011
5	Disease Progression 01/2021 - 07/2004
4	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2009
3	Body Weight (Weight, Body) 10/2019 - 10/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2015
2	COVID-19 01/2021 - 01/2021
1	Gastritis 04/2023
1	Cytomegalovirus Infections (Inclusion Disease) 04/2023
1	Infections 04/2023
1	Genomic Instability 02/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Dyslipidemias (Dyslipidemia) 10/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Carcinogenesis 01/2021
1	Hepatitis 10/2020
1	Colitis 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 11/2019
1	Microsatellite Instability 01/2019
1	Turcot syndrome 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Colonic Neoplasms (Colon Cancer) 04/2014
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Neutropenia 01/2011

Drug/Important Bio-Agent (IBA)

11	Sunitinib (Sutent)FDA Link 10/2022 - 08/2009
9	Immune Checkpoint InhibitorsIBA 01/2024 - 05/2017
7	IpilimumabIBA 03/2024 - 10/2017
5	NivolumabIBA 02/2023 - 10/2017
3	Axitinib (AG 013736)IBA 10/2022 - 01/2019
3	avelumabIBA 10/2022 - 01/2019
2	AntigensIBA 01/2023 - 07/2004
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 05/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
2	B7-H1 AntigenIBA 01/2019 - 10/2017
1	Interleukin-2 (IL2)IBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	pembrolizumabIBA 04/2023
1	Adenosine (Adenocard)FDA LinkGeneric 02/2023
1	Tryptophan (L-Tryptophan)FDA Link 02/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2021
1	VaccinesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	AntibodiesIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Microphthalmia-Associated Transcription FactorIBA 12/2014
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 04/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2014
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 04/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	ErbB Receptors (EGF Receptor)IBA 04/2014
1	ChromatinIBA 04/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014
1	CytokinesIBA 01/2011
1	Dihydrotachysterol (AT 10)IBA 01/2011
1	VemurafenibIBA 01/2011
1	interleukin-21 (interleukin 21)IBA 01/2011
1	peginterferon alfa-2b (Pegintron)FDA Link 07/2005
1	Interferon alpha-2 (Roferon-A)FDA Link 07/2005
1	Differentiation AntigensIBA 07/2004

Therapy/Procedure

14	Therapeutics 01/2024 - 02/2014
10	Nephrectomy 01/2022 - 09/2011
5	Immunotherapy 02/2023 - 08/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 04/2022 - 01/2015
1	Lasers (Laser) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Tattooing 01/2021
1	Investigational Therapies (Experimental Therapy) 07/2020
1	Neoadjuvant Therapy 01/2019
1	Radiotherapy 01/2015
1	Metastasectomy 02/2014
1	Cytoreduction Surgical Procedures 08/2009